Optimizing Guideline-directed Medical Therapies for Heart Failure with Reduced Ejection Fraction During Hospitalization
Heart failure remains a huge societal concern despite medical advancement, with an annual direct cost of over $30 billion. While guideline-directed medical therapy (GDMT) is proven to reduce morbidity and mortality, many eligible patients with heart failure with reduced ejection fraction (HFrEF) are...
Saved in:
Main Authors: | Neal M Dixit, Shivani Shah, Boback Ziaeian, Gregg C Fonarow, Jeffrey J Hsu |
---|---|
Format: | article |
Language: | EN |
Published: |
Radcliffe Medical Media
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/ca54115097ca404abb834a9b50fca39c |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Gap to Fill: Rationale for Rapid Initiation and Optimal Titration of Comprehensive Disease-modifying Medical Therapy for Heart Failure with Reduced Ejection Fraction
by: Nicholas K Brownell, et al.
Published: (2021) -
Determinants of gait speed in patients with heart failure with reduced ejection fraction
by: Aylin Tanrıverdi, et al.
Published: (2021) -
Role of nutritional supplementation in heart failure with reduced ejection fraction
by: Yash Paul Sharma, et al.
Published: (2021) -
Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
by: M Rizzo, et al.
Published: (2020) -
Classification of heart failure: A farewell to ejection fraction?
by: Thomas F. Lüscher
Published: (2021)